[blog-archive-images]
Artificial sweeteners have become deeply embedded in our global food system.
Also known as non-nutritive sweeteners (NNS) or non-sugar sweeteners, they are widely promoted as healthier alternatives to sugar. Offering sweetness without caloric intake they appeal to individuals seeking weight loss, glycaemic control, or reduced sugar consumption.
Regulatory agencies such as the Food Standards Agency and European Food Safety Authority (EFSA) have approved several artificial sweeteners as safe within established acceptable daily intake (ADI) limits. However, a growing body of scientific literature challenges the assumption that these compounds are physiologically inert.
Emerging evidence suggests that artificial sweeteners may contribute to metabolic dysfunction, cardiovascular disease, gut microbiome disruption, and other adverse health outcomes.
Reducing calories, but worse for health?
The global rise in obesity, diabetes, and metabolic disorders has intensified public interest in sugar alternatives. Artificial sweeteners such as aspartame, sucralose, saccharin, and acesulfame‑K have been marketed as tools to reduce caloric intake and mitigate the health risks associated with excessive sugar consumption.
Recent research indicates that artificial sweeteners may influence metabolic pathways, cardiovascular function, gut microbial composition, and cellular processes in ways that challenge their reputation as harmless sugar substitutes.
Artificial sweeteners provide sweetness without corresponding caloric content, potentially disrupting the body’s learned association between sweet taste and energy intake. This mismatch may impair metabolic signalling pathways, leading to increased appetite, altered insulin responses, and compensatory overeating.
Several studies suggest that chronic exposure to artificial sweeteners may reduce the body’s ability to regulate glucose effectively. For example, Suez et al. demonstrated that artificial sweeteners can induce glucose intolerance in both mice and humans by altering gut microbiota composition [1].
A sweet paradox
Paradoxically – considering they are eaten largely to reduce calories – artificial sweeteners have been linked to increased risk of obesity and metabolic syndrome. A systematic review and meta‑analysis by Azad et al. found that consumption of non‑nutritive sweeteners was associated with long‑term increases in body mass index (BMI), waist circumference, and incidence of obesity [2].
Similarly, the World Health Organization’s 2022 guideline concluded that non‑sugar sweeteners do not confer long‑term benefits for weight management and may increase the risk of type 2 diabetes and cardiovascular disease [3].
Further research indicates that certain artificial sweeteners may impair glucose tolerance. Sucralose, for example, has been shown to alter insulin sensitivity and contribute to glucose dysregulation. Ahmad et al. reported that several artificial sweeteners negatively affect glucose tolerance through microbiome‑mediated mechanisms [4]. These findings are particularly concerning for individuals using artificial sweeteners to manage diabetes or prediabetes.
Heart problems?
It’s not just obesity and metabolic disorders which appear problematic. Recent epidemiological studies have raised concerns about the relationship between artificial sweetener consumption and cardiovascular disease (CVD).
A landmark 2022 cohort study published in The BMJ found that higher intake of artificial sweeteners was associated with an increased risk of cardiovascular events, including coronary heart disease and stroke. The study, which analysed data from over 100,000 participants in the NutriNet‑Santé cohort, identified aspartame, acesulfame‑K, and sucralose as particularly concerning [5]. Participants with the highest consumption of artificial sweeteners had significantly greater risk of cerebrovascular events compared to those with lower intake.
Gut effects
The gut microbiome plays a critical role in digestion, immunity, and metabolic regulation. Artificial sweeteners appear to disrupt this complex ecosystem.
Multiple studies demonstrate that artificial sweeteners can alter gut bacterial populations. Sucralose, for example, has been shown to reduce beneficial gut bacteria and increase pro‑inflammatory species. Ahmad et al. found that several artificial sweeteners significantly altered gut microbiota composition, contributing to metabolic dysfunction [4].
Microbial diversity is a key indicator of gut health. Reduced diversity is associated with obesity, inflammatory bowel disease, and metabolic disorders. Artificial sweeteners may diminish microbial diversity, thereby increasing susceptibility to disease. Suez et al. demonstrated that artificial sweeteners induced dysbiosis in mice, leading to glucose intolerance [1].
Mixed effects
Sweeteners are often consumed with other additives at the same time. This can complicate the picture considerably as to their effects in people (rather than laboratory testing) – potentially increasing some of the effects.
The Slow Food message of eating real food, food that is ‘Good, Clean and Fair’, avoids the use of artificial sweeteners completely. It’s a message we have had for four decades, and now the recently-emerging science appears to back us up.
- Suez J, Korem T, Zilberman‑Schapira G, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514(7521):181‑186.
- Azad MB, Abou‑Setta AM, Chauhan BF, et al. Nonnutritive sweeteners and cardiometabolic health: A systematic review and meta‑analysis of randomized controlled trials and prospective cohort studies. CMAJ. 2017;189(28):E929‑E939.
- World Health Organization. Non‑sugar sweeteners: WHO guideline. Geneva: WHO Press; 2022.
- Ahmad SY, Friel J, Mackay DS. The effects of non‑nutritive artificial sweeteners on the microbiome and glucose tolerance: A systematic review. Nutrients. 2020;12(11):1‑22.
- Debras C, Chazelas E, Srour B, et al. Artificial sweeteners and risk of cardiovascular diseases: Results from the NutriNet‑Santé cohort. BMJ. 2022;378:e071204.
